Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danilo Swann Matassa

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Cells|June 6, 2019
HSP90 Molecular Chaperones, Metabolic Rewiring, and Epigenetics: Impact on Tumor Progression and Perspective for Anticancer TherapyValentina Condelli, Fabiana Crispo, Michele Pietrafesa, et al.
Scientific Reports|June 18, 2017
Regulation of sub-compartmental targeting and folding properties of the Prion-like protein ShadooAnna Pepe, Rosario Avolio, Danilo Swann Matassa, et al.
Advances in Protein Chemistry and Structural Biology|April 22, 2017
Stress-Adaptive Response in Ovarian Cancer Drug Resistance: Role of TRAP1 in Oxidative Metabolism-Driven InflammationMaria Rosaria Amoroso, Danilo Swann Matassa, Ilenia Agliarulo, et al.
RNA (New York, N.Y.)|September 2, 2025
The molecular chaperone TRAP1 promotes translation of <i>Luc7l3</i> mRNA to enhance ovarian cancer cell proliferationSabrina De Lella, Lorenza Pedalino, Mehad Almagboul Abdalla Abaker, et al.
Expert Opinion on Therapeutic Targets|July 1, 2017
TRAP1: a viable therapeutic target for future cancer treatments?Giacomo Lettini, Francesca Maddalena, Lorenza Sisinni, et al.
Oncotarget|June 19, 2015
Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinomaValentina Condelli, Francesca Maddalena, Lorenza Sisinni, et al.
Molecular Oncology|June 6, 2013
Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1Francesca Maddalena, Lorenza Sisinni, Giacomo Lettini, et al.
Cancer Research|November 5, 2011
Sorcin induces a drug-resistant phenotype in human colorectal cancer by modulating Ca(2+) homeostasisFrancesca Maddalena, Gabriella Laudiero, Annamaria Piscazzi, et al.
Cancer Cell International|December 12, 2022
Regulation of mitochondrial complex III activity and assembly by TRAP1 in cancer cellsDanilo Swann Matassa, Daniela Criscuolo, Rosario Avolio, et al.
Cancer Research|September 21, 2014
TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphorylation and cell-cycle progression: a novel target for BRAF-mutated colorectal tumorsValentina Condelli, Annamaria Piscazzi, Lorenza Sisinni, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Cells|June 6, 2019
HSP90 Molecular Chaperones, Metabolic Rewiring, and Epigenetics: Impact on Tumor Progression and Perspective for Anticancer TherapyValentina Condelli, Fabiana Crispo, Michele Pietrafesa, et al.
Scientific Reports|June 18, 2017
Regulation of sub-compartmental targeting and folding properties of the Prion-like protein ShadooAnna Pepe, Rosario Avolio, Danilo Swann Matassa, et al.
Advances in Protein Chemistry and Structural Biology|April 22, 2017
Stress-Adaptive Response in Ovarian Cancer Drug Resistance: Role of TRAP1 in Oxidative Metabolism-Driven InflammationMaria Rosaria Amoroso, Danilo Swann Matassa, Ilenia Agliarulo, et al.
RNA (New York, N.Y.)|September 2, 2025
The molecular chaperone TRAP1 promotes translation of <i>Luc7l3</i> mRNA to enhance ovarian cancer cell proliferationSabrina De Lella, Lorenza Pedalino, Mehad Almagboul Abdalla Abaker, et al.
Expert Opinion on Therapeutic Targets|July 1, 2017
TRAP1: a viable therapeutic target for future cancer treatments?Giacomo Lettini, Francesca Maddalena, Lorenza Sisinni, et al.
Oncotarget|June 19, 2015
Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinomaValentina Condelli, Francesca Maddalena, Lorenza Sisinni, et al.
Molecular Oncology|June 6, 2013
Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1Francesca Maddalena, Lorenza Sisinni, Giacomo Lettini, et al.
Cancer Research|November 5, 2011
Sorcin induces a drug-resistant phenotype in human colorectal cancer by modulating Ca(2+) homeostasisFrancesca Maddalena, Gabriella Laudiero, Annamaria Piscazzi, et al.
Cancer Cell International|December 12, 2022
Regulation of mitochondrial complex III activity and assembly by TRAP1 in cancer cellsDanilo Swann Matassa, Daniela Criscuolo, Rosario Avolio, et al.
Cancer Research|September 21, 2014
TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphorylation and cell-cycle progression: a novel target for BRAF-mutated colorectal tumorsValentina Condelli, Annamaria Piscazzi, Lorenza Sisinni, et al.
Pageof 4